Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (7504)	1/18/2000 11:12:00 PM
From: RWReeves	Read Replies (1) \| Respond to of 9719

CA vaccines and tumor directed therapies seem to have gotten a lot more interest, perhaps due to the fairly incisive CLTR debates a few months ago and some improving data. NERX has moved well but not as far as IMMU which broke out today along with BIOM. There is another one to add to the fold, but I think I'll keep my big mouth shut on it until I have a position <g>. Sadly I sold BIOM on the previous runup hoping to buy back at 3. Buy AND Hold and Buy AND Hold... RWR BTW Don't know if ELN fits the VD model portfolio criteria for your contemplation, but it's looking pretty lonely.